U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...